Kapitalradar

Swiss capital increases, read from the official gazette and scored for financing rounds.

updated every weekdayrelease r9data as of 8 Oct 2026

↺ Try a rewind: Soverli AG on 24 Sep 2025, 83 days before the round was announced
Latest available record · 8 Oct 2026

Release evaluation · 7 Oct 2026 · does not rewind · rules + Claude: precision 2%–100% (n=17), recall 16/30 announced rounds · rules-only: precision 1%–99% (n=29), recall 18/30 announced rounds · Methodology

Published by 13 Sep 2026
Drag the red line through time · ← → a day · Shift+← → a week. Later days aren’t drawn: they haven’t been published yet.
1733not yet publishedAug 25Sep 25Oct 25Nov 25Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26

Scope · likely financings by canton

36 likely financings · 15 Aug 2026 – 13 Sep 2026 · the feed below shows one weekZH ✕ show all cantonsMap: Natural Earth

Likely financing
Looks like new money from outside investors: Claude, reading the entry and the rule signals, scores it 0.60 or higher.
Undecided
Some financing signals, not enough to call it: a score from 0.35 to below 0.60, or no usable score.
Capital increased
No sign of a financing round: the pre-filter found nothing to send to Claude, or Claude scored it below 0.35. Typical causes are converted loans, assets contributed in kind, reserves turned into capital or a conversion to an AG.
Confirmed round
A financing announcement on startupticker.ch names the company and matches this increase.

Published 7–13 Sep 2026 · canton ZH

13 capital increases · 5 shown
Showing: likely financings and confirmed rounds ▾
Show
Capital increases published 7–13 Sep 2026
CompanyStatusNominal share capital (CHF)
before → after		New shares, % of
post-step shares		Announced roundnot disclosed in the SHABSHAB publishedSource
Dascoli Pharma AGZH · Die Gesellschaft bezweckt den Betrieb von Apotheken, Handel mit Produkten aller Art, die direkt oder indirekt …SHAB publication HR02-1006752752Likely financingscore 0.60100’000 → 114’740.30New shares 12.8%12.8%—10 Sep 2026SHAB publication HR02-1006752752
Procavea Biotech AGZH · Die Gesellschaft bezweckt die Entwicklung, die Herstellung und den Verkauf von biotechnologischen, …SHAB publication HR02-1006751691Likely financingscore 0.65100’000 → 160’000New shares 37.5%37.5%—9 Sep 2026SHAB publication HR02-1006751691
Magnes AGZH · Zweck des Unternehmens ist die Entwicklung von tragbaren Geräten für Gesundheits- und Sportanwendungen, …SHAB publication HR02-1006750468Likely financingscore 0.80165’992.70 → 200’184New shares 17.1%17.1%—8 Sep 2026SHAB publication HR02-1006750468
Diaxxo AGZH · Zweck der Gesellschaft ist die Entwicklung und Vermarktung von Analysengeräten zur Nukleinsäure Bestimmung, …SHAB publication HR02-1006749222Likely financingscore 0.85125’977 → 164’000New shares 23.2%23.2%—7 Sep 2026SHAB publication HR02-1006749222
coatmaster AGZH · Die Gesellschaft bezweckt die Entwicklung, die Herstellung und den Vertrieb von Systemen für die …SHAB publication HR02-1006749217Likely financingscore 0.68564’508 → 699’611New shares 19.3%19.3%—7 Sep 2026SHAB publication HR02-1006749217

8 other capital increases published this week ▸